Identification
A:Infrared Absorption á197Kñ
Test specimen
Crush 1Tablet using a mortar and pestle.Prepare an approximate 1%w/w dispersion of the sample in potassium bromide:the Test specimenshows strong bands at about 1690,1560,and 1240cm1and a weaker band at about 790cm1similar to the reference preparation.
B:
The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that in the chromatogram of the Standard preparation,as obtained in the Assay.
Uniformity of dosage units á905ñ:
meet the requirements.
PROCEDURE FOR CONTENT UNIFORMITY
Standard solution
Dissolve an accurately weighed quantity of
USP Bupropion Hydrochloride RSin water to obtain a solution having a known concentration of about 0.33mg of bupropion hydrochloride per mL.
Test solution
Transfer 1Tablet to a suitable homogenizer vessel containing an accurately measured volume of water to obtain a concentration of about 0.33mg of bupropion hydrochloride per mL.Immediately homogenize the sample using single 30-second pulses each at 5000,10,000,and 15,000rpm,and follow by two pulses each at 20,000rpm.After the homogenate has settled,mix at 5000rpm for an additional 30seconds.Pass a portion of the solution through a nylon filter having a 0.45-µm porosity,discarding the first 4mLof the filtrate.
Procedure
Proceed as directed in the test for Drug release,except to use a 0.5-cm cell,taking into account the extent of dilution.
Related compounds
Solution A,Solution B,Mobile phase,System suitability solution 1,andSystem suitability solution 2
Proceed as directed in the Assay.
Test solution
Use the Assay preparation.
Chromatographic system
Proceed as directed in the Assay,except to use the Standard solutioninstead of the Standard preparation.
Procedure
Separately inject equal volumes (about 5µL)of the
Standard solutionand the
Test solutioninto the chromatograph,record the chromatograms,and measure the areas for the major peaks.Calculate the percentage of bupropion hydrochloride related compound Ein the portion of Tablets taken by the formula:
100(C/D)(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Bupropion Hydrochloride Related Compound E RSin the
Standard solution;Dis the concentration,in mg per mL,of bupropion hydrochloride in the
Test solution,based on the number of Tablets taken,the labeled quantity per Tablet,and the extent of dilution;and
rUand
rSare the peak responses for bupropion hydrochloride related compound Eobtained from the
Test solutionand the
Standard solution,respectively:not more than 0.4%of bupropion hydrochloride related compound Eis found.Calculate the percentage of each additional impurity in the portion of Tablets taken by the formula:
100F(ri/rS),
in which
Fis the relative response factor for each impurity (see the accompanying table for values);
riis the peak response for each impurity obtained from the
Test solution;and
rSis the peak response for bupropion hydrochloride obtained from the
Standard solution.See the accompanying table for limits of individual impurities based upon Tablet strength.
|
Relative |
|
Limit (%) |
| Compound |
Retention Time |
F |
100mg or less |
150mg or greater |
Specified impurity 1 |
0.38 |
0.80 |
0.3 |
0.3 |
Specified impurity 2 |
0.56 |
0.86 |
1.0 |
1.0 |
Specified impurity 3 |
0.78 |
0.88 |
0.5 |
0.4 |
Bupropion related compound F |
1.71 |
0.55 |
1.2 |
2.3 |
Bupropion related compound C |
1.75 |
0.59 |
0.3 |
0.3 |
m-Chloro benzoic acid |
1.80 |
0.24 |
0.3 |
0.3 |
Bupropion related compound E |
2.25 |
1.00 |
0.4 |
0.4 |
| Any unspeci fied impurity |
|
1.00 |
0.2 |
0.2 |
Total impuri ties |
|
|
3.2 |
3.3 |
Assay
Solution A
Prepare a filtered and degassed mixture of water,acetonitrile,and trifluoroacetic acid (90:10:0.04).
Solution B
Prepare a filtered and degassed mixture of acetonitrile,water,and trifluoroacetic acid (95:5:0.03).
Mobile phase
Use variable mixtures of
Solution Aand
Solution Bas directed for
Chromatographic system.Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
System suitability solution 1
Prepare separate solutions containing accurately weighed quantities of
USP Bupropion Hydrochloride Related Compound C RSand USP Bupropion Hydrochloride Related Compound F RSin methanol to obtain solutions having concentrations of about 0.20mg per mL.Transfer accurately measured volumes of these solutions to a suitable flask,and dilute with a mixture of 0.001Nhydrochloric acid and methanol (80:20)to obtain a solution having a concentration of about 0.0018mg of
USP Bupropion Hydrochloride Related Compound C RSper mLand 0.018mg of USP Bupropion Hydrochloride Related Compound F RSper mL.
System suitability solution 2
Prepare a solution containing an accurately weighed quantity of m-chlorobenzoic acid to obtain a solution having a concentration of about 0.09mg per mL.Dilute an accurately measured volume of this solution with a mixture of 0.001Nhydrochloric acid and methanol (80:20)to obtain a solution having a concentration of about 0.0018mg of m-chlorobenzoic acid per mL.
Standard preparation
Dissolve an accurately weighed quantity of
USP Bupropion Hydrochloride RSin a mixture of 0.001Nhydrochloric acid and methanol (80:20)to obtain a solution having a known concentration of about 0.6mg of bupropion hydrochloride per mL.
Assay preparation
Transfer a number of Tablets to a suitable homogenizer vessel containing an accurately measured volume of methanol to obtain a concentration of about 3.0mg of bupropion hydrochloride per mL.Immediately homogenize the sample for 30seconds at 20,000rpm.Allow to extract for 3minutes,and follow by two additional 10-second pulses,each at 20,000rpm,pausing 3minutes between these pulses to ensure complete extraction.Pass a portion of the solution through a nylon filter having a 0.45-µm porosity,discarding the first 2to 4mLof the filtrate.Pipet 10.0mLof the filtrate into a 50-mLvolumetric flask,and add about 25mLof 0.001Nhydrochloric acid.Allow to cool to room temperature,and dilute with 0.001Nhydrochloric acid to volume.
Chromatographic system (see Chromatography á621ñ)
The liquid chromatograph is equipped with a 226-nm detector and a 4.6-mm ×10-cm column that contains 3.5-µm packing L1.The flow rate is about 1.5mLper minute.The chromatograph is programmed as follows.
Time (minutes) |
Solution A
(%) |
Solution B
(%) |
Elution |
| 0 |
90 |
10 |
equilibration |
| 03.4 |
90®87 |
10®13 |
linear gradient |
| 3.410.0 |
87®15 |
13®85 |
linear gradient |
| 10.010.1 |
15®0 |
85®100 |
linear gradient |
| 10.113.0 |
0 |
100 |
isocratic |
| 13.013.2 |
0®90 |
100®10 |
linear gradient |
| 13.219.0 |
90 |
10 |
isocratic |
Chromatograph
System suitability solution 1,System suitability solution 2,and the
Standard preparation,and record the peak areas as directed for
Procedure:the resolution,
R,between bupropion hydrochloride related compound Cand bupropion hydrochloride related compound Fis not less than 1.5;the relative response factor for
System suitability solution 2is between 0.22and 0.26when calculated using the peak obtained in the
Standard preparation;the tailing factor is not more than 1.9;and the relative standard deviation for replicate injections of the
Standard preparationis not more than 1.5%.
Procedure
Separately inject equal volumes (about 5µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the areas for the major peaks.Calculate the amount,in mg,of bupropion hydrochloride (C
13H
18ClNO·HCl)in the portion of Tablets taken by the formula:
(TC/D)(rU/rS),
in which Tis the labeled quantity,in mg,of bupropion hydrochloride in the Tablet;
Cis the concentration,in mg per mL,of
USP Bupropion Hydrochloride RSin the
Standard preparation;Dis the concentration,in mg per mL,of bupropion hydrochloride in the
Assay preparation,based upon the labeled quantity per Tablet and the extent of dilution;and
rUand
rSare the peak responses for bupropion hydrochloride obtained from the
Assay preparationand the
Standard preparation,respectively.